Houston, Texas-based Camden Property Trust (CPT) is a real estate investment trust (REIT) primarily engaged in the ownership, management, development, repositioning, redevelopment, acquisition, and construction of multifamily apartment communities. With a market cap of $12.3 billion, it owns and operates approximately 176 properties containing over 59,647 apartment homes across the United States.
Companies worth $10 billion or more are generally described as “large-cap” stocks, and Camden Property Trust fits this criterion perfectly. The company operates a portfolio of high-quality apartment properties across major U.S. markets, with a focus on the Sunbelt region.
Shares of Camden Property Trust have declined 9.5% from its 52-week high of $127.69. CPT stock has dropped 5% over the past three months, a steeper decline than the iShares Residential and Multisector Real Estate ETF’s (REZ) 2.9% decrease.
Longer term, shares of CPT have decreased marginally on a YTD basis, underperforming REZ’s 2.3% uptick over the same time frame. Moreover, Camden Property Trust’s stock has risen 4% over the past 52 weeks, compared to REZ’s 7.5% gain.
Despite some fluctuations, the stock has been trading below its 50-day and 200-day moving averages since early April. However, the stock has risen above its 50-day moving average since May.
Camden Property Trust’s stock surged 5.3% following the release of its solid Q1 2025 results on May 1. Quarterly operating revenue rose 1.9% from the year-ago quarter to $390.6 million, exceeding Street forecasts. The same-property occupancy improved to 95.4%, up 40 basis points (bps) from the prior year quarter. Its core FFO grew 1.2% year-over-year to $1.72 per share, also topping the consensus estimate by 2.4%.
Looking ahead, the company raised its full-year 2025 guidance, now expecting core FFO per share in the range of $6.63 to $6.93, up from the previous outlook of $6.60 to $6.90, further boosting investor confidence.
Compared to its rival, Essex Property Trust, Inc. (ESS) has underperformed the CPT stock over the past 52 weeks, gaining 2.5%. Nevertheless, shares of ESS have increased marginally on a YTD basis, slightly outpacing CPT stock.
While CPT has underperformed, analysts are moderately optimistic about its prospects. The stock has a consensus rating of “Moderate Buy” from the 26 analysts covering the stock. As of writing, the stock is trading below the mean price target of $129.77.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
